Pharma is sexy. Big drugs, big money, big news. In the life sciences arena, perhaps only biotech commands a higher political and public profile.
So it isn’t surprising that the medical device industry’s groundbreaking inclusion in Massachusetts’ new code of conduct garnered relatively little attention.
But the new rules governing industry payments to physicians — the so-called “gift ban” — include provisions aimed at curbing what some call undue and improper influence by medical device manufacturers.